FindTrial
Sign In

Predicting the progression and adverse prognosis of chronic kidney disease with multi-omics and clinical multi-dimensional data

Predicting the progression and adverse prognosis of chronic kidney disease with multi-omics and clinical multi-dimensional data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079828
Enrollment
Unknown
Registered
2024-01-12
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease (CKD)

Interventions

CKD observation group:None

Sponsors

West China Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: ? Patients with CKD stages 3-5D; ? Aged 18-74 years; ? Signed informed consent form.

Exclusion criteria

Exclusion criteria: ? Incapable of signing the informed consent form; ? Pregnant; ? New York Heart Association functional class III-IV; ? Diagnosed with any of the following diseases: human immunodeficiency virus infection, cirrhosis, multiple myeloma; ? Other clinical conditions deemed severe or unsuitable for participation in the study by the attending physician.

Design outcomes

Primary

MeasureTime frame
All-cause death;Cardiovascular death;—

Secondary

MeasureTime frame
Cardiovascular events;Disturbance of electrolytes and acid-base balance;—

Countries

China

Contacts

Public ContactXiaoxi ZENG

West China Hospital, Sichuan Universtiy

zengxiaoxi@wchscu.cn+86 28 8452 2819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026